Rosiglitazone, a peroxisome proliferator-activated receptor agonist, improves peritoneal alterations resulting from an encapsulated peritoneal sclerosis model.

Advances in peritoneal dialysis. Conference on Peritoneal Dialysis

Volumn 24, Issue , 2008, Pages 32-38

  Bozkurt, Devrim ^a   Taskin, Hüseyin ^a   Sezak, Murat ^a   Biçak, Selahattin ^a   Sen, Sait ^a   Ok, Ercan ^a   Duman, Soner ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; ROSIGLITAZONE;

ANIMAL; ARTICLE; DRUG POTENTIATION; FEMALE; PATHOLOGY; PERITONEAL DIALYSIS; PERITONEAL DISEASE; PERITONEUM; RAT; SCLEROSIS; WISTAR RAT;

ANIMALS; FEMALE; PERITONEAL DIALYSIS; PERITONEAL DISEASES; PERITONEUM; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; RATS; RATS, WISTAR; SCLEROSIS; THIAZOLIDINEDIONES;

EID: 58149241010     PISSN: 11978554     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)